Klebsiella pneumoniae producing KPC is a great health concern and therapy with ceftazidime-avibactam represent a choice for the treatment of infections supported by these strains. We report a ceftazidime-avibactam resistant strain by a deletion of 6 nucleotides in the blaKPC gene sequence.

Klebsiella pneumoniae carbapenemase (KPC) producer resistant to ceftazidime–avibactam due to a deletion in the blaKPC3 gene

Antinori, Elisa;Unali, Ilaria;Bertoncelli, Anna;Mazzariol, Annarita
2020-01-01

Abstract

Klebsiella pneumoniae producing KPC is a great health concern and therapy with ceftazidime-avibactam represent a choice for the treatment of infections supported by these strains. We report a ceftazidime-avibactam resistant strain by a deletion of 6 nucleotides in the blaKPC gene sequence.
2020
KPC carbapenemase; KPC deletion; KPC mutations; KPC producing K. pneumoniae; ceftazidime-avibactam resistance
File in questo prodotto:
Non ci sono file associati a questo prodotto.

I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificativo per citare o creare un link a questo documento: https://hdl.handle.net/11562/1011943
Citazioni
  • ???jsp.display-item.citation.pmc??? 7
  • Scopus 17
  • ???jsp.display-item.citation.isi??? 18
social impact